EUVIMEDEUVIMED entdecken
Crossref

Real-Life Adherence to Venom Immunotherapy and Adrenaline Autoinjector

Louise Parke, Henrik Fomsgaard Kjaer, Olav Sivertsen Garvik, Susanne Halken, Sigurd Broesby-Olsen, Carsten Bindslev-Jensen, Charlotte G Mortz

International Archives of Allergy and Immunology · 2024

DOI: 10.1159/000535294 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Archives of Allergy and Immunology, 2024. Verfasst von Louise Parke und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Allergy Center, Odense Research Center for Anaphylaxis (ORCA), Odense University Hospital, Odense, Denmark. Hauptthemen laut MEDLINE: Insect Bites and Stings, Venom Hypersensitivity, Anaphylaxis, Mastocytosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Venom immunotherapy (VIT) and adrenaline autoinjector (AAI) are important therapies in venom anaphylaxis. Adherence to VIT and AAI in patients with venom allergy has been evaluated in a few studies; however, solid data are lacking. This study aimed to evaluate VIT and AAI retrieval rates in patients with venom allergy with a special focus on adherence to treatment. Adherence was compared to subcutaneous immunotherapy (SCIT) with inhalant allergens.

Methods

This was a retrospective study among patients registered for allergen immunotherapy at the Allergy Center, Odense University Hospital, Denmark, from January 1, 2010, to December 31, 2014. Data on purchased immunotherapy and AAI were obtained from the Danish National Health Service Prescription Database. Multivariable logistic regression was used to analyze if allergen, age, sex, mastocytosis, and treatment site affected adherence.

Results

The 3-year adherence to VIT was 92.4% (244/264) compared to 87.4% (215/246) in SCIT with inhalant allergens, and the 5-year adherence to VIT was 84.1% (222/264) compared to 74.8% (184/246) in SCIT with inhalant allergens (p = 0.045). Females treated with VIT were more adherent than males (p = 0.45 [3-year], p = 0.008 [5-year]), whereas allergen, age, mastocytosis, or treatment site did not significantly affect adherence. Only 28.6% of patients (12/42) purchased an AAI after premature termination of VIT.

Conclusion

In this register-based study, we found that the 3- and 5-year adherences to VIT and SCIT with inhalant allergens are at the upper end of the spectrum hitherto reported. Patients’ 5-year adherence to VIT was higher than patients’ 5-year adherence to SCIT with inhalant allergens. If VIT was prematurely terminated, less than 1/3 would have purchased an AAI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insect Bites and StingsVenom HypersensitivityAnaphylaxisMastocytosisMaleFemaleHumansEpinephrineRetrospective StudiesState MedicineDesensitization, ImmunologicAllergensImmunotherapy

Stichwörter der Autor:innen

Adrenaline autoinjectorAnaphylaxisVenom allergyVenom immunotherapy

Substanzen

EpinephrineAllergens

Autor:innen und Institutionen

  • Department of Dermatology and Allergy Center, Odense Research Center for Anaphylaxis (ORCA), Odense University Hospital, Odense, Denmark.
  • Institute of Clinical Research, Center for Clinical Epidemiology, Odense University Hospital, and Research Unit of Clinical Epidemiology, University of Southern Denmark, Odense, Denmark.
  • Hans Christian Andersen Children's Hospital, Odense University Hospital, Odense, Denmark.

Zitieren

APA

Parke, L., Fomsgaard Kjaer, H., Sivertsen Garvik, O., Halken, S., Broesby-Olsen, S., Bindslev-Jensen, C., & Mortz, C. G. (2024). Real-Life Adherence to Venom Immunotherapy and Adrenaline Autoinjector. International Archives of Allergy and Immunology. https://doi.org/10.1159/000535294

Vancouver

Parke L, Fomsgaard Kjaer H, Sivertsen Garvik O, Halken S, Broesby-Olsen S, Bindslev-Jensen C, et al. Real-Life Adherence to Venom Immunotherapy and Adrenaline Autoinjector. International Archives of Allergy and Immunology. 2024. doi:10.1159/000535294

BibTeX
@article{Parke2024,
  author = {Parke, Louise and Fomsgaard Kjaer, Henrik and Sivertsen Garvik, Olav and Halken, Susanne and Broesby-Olsen, Sigurd and Bindslev-Jensen, Carsten and Mortz, Charlotte G},
  title = {Real-Life Adherence to Venom Immunotherapy and Adrenaline Autoinjector},
  journal = {International Archives of Allergy and Immunology},
  year = {2024},
  doi = {10.1159/000535294}
}
Kostenlos starten →